{"id":"https://openalex.org/W7127098418","doi":"https://doi.org/10.1016/j.supflu.2026.106922","title":"Engineering Acyclovir-PVP coprecipitated microparticles obtained via different supercritical processes","display_name":"Engineering Acyclovir-PVP coprecipitated microparticles obtained via different supercritical processes","publication_year":2026,"publication_date":"2026-02-03","ids":{"openalex":"https://openalex.org/W7127098418","doi":"https://doi.org/10.1016/j.supflu.2026.106922"},"language":"en","primary_location":{"id":"doi:10.1016/j.supflu.2026.106922","doi":"https://doi.org/10.1016/j.supflu.2026.106922","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.supflu.2026.106922","pdf_url":null,"source":{"id":"https://openalex.org/S12574399","display_name":"The Journal of Supercritical Fluids","issn_l":"0896-8446","issn":["0896-8446","1872-8162"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Supercritical Fluids","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.supflu.2026.106922","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104649011","display_name":"Maria Chiara Iannaco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I131729948","display_name":"University of Salerno","ror":"https://ror.org/0192m2k53","country_code":"IT","type":"education","lineage":["https://openalex.org/I131729948"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Chiara Iannaco","raw_affiliation_strings":["Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy","institution_ids":["https://openalex.org/I131729948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088296113","display_name":"Stefania Mottola","orcid":"https://orcid.org/0000-0002-2534-8359","observed_orcids":["https://orcid.org/0000-0002-2534-8359"]},"institutions":[{"id":"https://openalex.org/I131729948","display_name":"University of Salerno","ror":"https://ror.org/0192m2k53","country_code":"IT","type":"education","lineage":["https://openalex.org/I131729948"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefania Mottola","raw_affiliation_strings":["Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy"],"raw_orcid":"https://orcid.org/0000-0002-2534-8359","affiliations":[{"raw_affiliation_string":"Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy","institution_ids":["https://openalex.org/I131729948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001572429","display_name":"Iolanda De Marco","orcid":"https://orcid.org/0000-0002-8975-6861","observed_orcids":["https://orcid.org/0000-0002-8975-6861"]},"institutions":[{"id":"https://openalex.org/I131729948","display_name":"University of Salerno","ror":"https://ror.org/0192m2k53","country_code":"IT","type":"education","lineage":["https://openalex.org/I131729948"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Iolanda De Marco","raw_affiliation_strings":["Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy"],"raw_orcid":"https://orcid.org/0000-0002-8975-6861","affiliations":[{"raw_affiliation_string":"Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy","institution_ids":["https://openalex.org/I131729948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001572429"],"corresponding_institution_ids":["https://openalex.org/I131729948"],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":9.1248,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.97119871,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"232","issue":null,"first_page":"106922","last_page":"106922"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10402","display_name":"Phase Equilibria and Thermodynamics","score":0.050599999725818634,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.04410000145435333,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acyclovir","display_name":"acyclovir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/coprecipitation","display_name":"co-precipitation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/microparticles","display_name":"microparticles","score":0.878000020980835},{"id":"https://openalex.org/keywords/particle-size-distribution","display_name":"particle size distribution","score":0.7049999833106995},{"id":"https://openalex.org/keywords/drug-loading-efficiency","display_name":"drug loading efficiency","score":0.8370000123977661},{"id":"https://openalex.org/keywords/controlled-release","display_name":"controlled release","score":0.5989999771118164},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.6159999966621399},{"id":"https://openalex.org/keywords/bioavailability-enhancement","display_name":"bioavailability enhancement","score":0.7670000195503235},{"id":"https://openalex.org/keywords/poorly-permeable-drugs","display_name":"poorly permeable drugs","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C118419359","wikidata":"https://www.wikidata.org/wiki/Q682585","display_name":"Supercritical fluid","level":2,"score":0.9286999702453613},{"id":"https://openalex.org/C28737856","wikidata":"https://www.wikidata.org/wiki/Q870531","display_name":"Coprecipitation","level":2,"score":0.9031999707221985},{"id":"https://openalex.org/C86178769","wikidata":"https://www.wikidata.org/wiki/Q1130789","display_name":"Micronization","level":3,"score":0.8968999981880188},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.7142999768257141},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.6908000111579895},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6754999756813049},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5385000109672546},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.5249999761581421},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5031999945640564},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.4684999883174896},{"id":"https://openalex.org/C2778517922","wikidata":"https://www.wikidata.org/wiki/Q7140482","display_name":"Particle (ecology)","level":2,"score":0.4361000061035156},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.41110000014305115},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.38260000944137573},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.3747999966144562},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.37139999866485596},{"id":"https://openalex.org/C2777521759","wikidata":"https://www.wikidata.org/wiki/Q61186","display_name":"Microparticle","level":2,"score":0.37049999833106995},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36149999499320984},{"id":"https://openalex.org/C107054158","wikidata":"https://www.wikidata.org/wiki/Q25257","display_name":"Precipitation","level":2,"score":0.3276999890804291},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.3107999861240387},{"id":"https://openalex.org/C60448018","wikidata":"https://www.wikidata.org/wiki/Q2054937","display_name":"Particle-size distribution","level":3,"score":0.3082999885082245},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30160000920295715},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.27410000562667847},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.2734000086784363}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.supflu.2026.106922","doi":"https://doi.org/10.1016/j.supflu.2026.106922","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.supflu.2026.106922","pdf_url":null,"source":{"id":"https://openalex.org/S12574399","display_name":"The Journal of Supercritical Fluids","issn_l":"0896-8446","issn":["0896-8446","1872-8162"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Supercritical Fluids","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.supflu.2026.106922","doi":"https://doi.org/10.1016/j.supflu.2026.106922","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.supflu.2026.106922","pdf_url":null,"source":{"id":"https://openalex.org/S12574399","display_name":"The Journal of Supercritical Fluids","issn_l":"0896-8446","issn":["0896-8446","1872-8162"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Supercritical Fluids","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4198133647441864}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W948496184","https://openalex.org/W1543696264","https://openalex.org/W1681509264","https://openalex.org/W1923989282","https://openalex.org/W1977993705","https://openalex.org/W1986896081","https://openalex.org/W1989828249","https://openalex.org/W2008503709","https://openalex.org/W2024263679","https://openalex.org/W2032299999","https://openalex.org/W2034371639","https://openalex.org/W2043457846","https://openalex.org/W2064147751","https://openalex.org/W2067332497","https://openalex.org/W2081237311","https://openalex.org/W2082538921","https://openalex.org/W2125645644","https://openalex.org/W2133739550","https://openalex.org/W2136554631","https://openalex.org/W2144175913","https://openalex.org/W2312270785","https://openalex.org/W2316305032","https://openalex.org/W2413369916","https://openalex.org/W2515046059","https://openalex.org/W2530708261","https://openalex.org/W2548829912","https://openalex.org/W2729317747","https://openalex.org/W2743375793","https://openalex.org/W2773118898","https://openalex.org/W2785039470","https://openalex.org/W2801188978","https://openalex.org/W2911150084","https://openalex.org/W2982259079","https://openalex.org/W2996901488","https://openalex.org/W3011035032","https://openalex.org/W3047377795","https://openalex.org/W3088408620","https://openalex.org/W3093209107","https://openalex.org/W3135798762","https://openalex.org/W3151492801","https://openalex.org/W3197911929","https://openalex.org/W3212593162","https://openalex.org/W3215628262","https://openalex.org/W4200286006","https://openalex.org/W4289639883","https://openalex.org/W4290999324","https://openalex.org/W4388948413","https://openalex.org/W4391110889","https://openalex.org/W4400010726","https://openalex.org/W4402564768","https://openalex.org/W4404700413","https://openalex.org/W4407095605","https://openalex.org/W4411092320"],"related_works":[],"abstract_inverted_index":{"Enhancing":[0],"the":[1,13,68,71,104,186,191,205],"release":[2,48,101,178,188],"profile":[3,102],"of":[4,30,70,77,103,193,207],"poorly":[5],"permeable":[6],"drugs":[7],"remains":[8],"a":[9,21,112,122],"major":[10],"challenge":[11],"in":[12,176,197,254],"pharmaceutical":[14],"field.":[15],"Coprecipitation":[16],"with":[17,86,111,138,168,209],"hydrophilic":[18],"polymers":[19],"offers":[20],"promising":[22,260],"strategy":[23],"to":[24,88,118],"address":[25],"this":[26],"issue.":[27],"The":[28,75,94,175],"performance":[29],"drug":[31,97,199,243],"delivery":[32],"systems":[33],"is":[34],"largely":[35],"influenced":[36],"by":[37,229],"particle":[38,89],"size,":[39],"shape,":[40],"and":[41,49,62,80,91,100,121,143,146,202,219,225,233],"distribution,":[42],"critical":[43],"factors":[44],"for":[45,67,164,172,262],"achieving":[46],"controlled":[47],"enhanced":[50,250],"bioavailability.":[51],"This":[52],"study":[53],"compares":[54],"two":[55],"micronization":[56],"techniques,":[57],"Supercritical":[58,63,257],"Assisted":[59],"Atomization":[60],"(SAA)":[61],"AntiSolvent":[64],"(SAS)":[65],"process,":[66],"coprecipitation":[69],"Acyclovir/Polyvinylpyrrolidone":[72],"(PVP)":[73],"system.":[74],"effects":[76],"polymer-to-drug":[78],"ratio":[79],"total":[81],"solute":[82,231],"concentration":[83,232],"were":[84,106,128,215,227],"evaluated":[85],"respect":[87],"morphology":[90,226],"size":[92,224],"distribution.":[93],"thermal":[95],"behavior,":[96],"loading":[98,162,244],"efficiency,":[99],"coprecipitates":[105],"also":[107],"examined.":[108],"Spherical":[109],"microparticles":[110,166,214],"D":[113,123,139,147],"50":[114,140],"ranging":[115],"from":[116],"0.54":[117],"0.93":[119],"\u03bcm":[120,145],"90":[124,148],"below":[125],"1.7":[126],"\u03bcm,":[127,152],"successfully":[129],"produced":[130,216,237],"via":[131,217],"SAA,":[132],"while":[133],"SAS":[134,173,220,236],"yielded":[135],"smaller":[136,238],"particles,":[137],"between":[141],"0.35":[142],"0.68":[144],"lower":[149,170],"than":[150],"1.06":[151],"indicating":[153],"high":[154,160],"sample":[155],"uniformity.":[156],"UV-vis":[157],"analysis":[158],"revealed":[159],"acyclovir":[161],"efficiencies":[163],"SAA":[165,218,240],"(80-98%),":[167],"slightly":[169],"values":[171],"(74-82%).":[174],"vitro":[177],"experiments":[179],"showed":[180],"that":[181],"incorporating":[182],"PVP":[183],"markedly":[184],"improved":[185],"drug\u2019s":[187],"profile,":[189],"supporting":[190],"effectiveness":[192],"supercritical":[194],"processing":[195],"methods":[196,248],"enhancing":[198],"dissolution":[200,252],"rate":[201,253],"potentially":[203],"improving":[204],"bioavailability":[206,263],"compounds":[208],"permeability-limited":[210],"absorption.":[211],"\u2022":[212,222,235,246,256],"Acyclovir/PVP":[213],"techniques.":[221],"Particle":[223],"tuned":[228],"varying":[230],"ratio.":[234],"particles;":[239],"achieved":[241],"higher":[242],"efficiency.":[245],"Both":[247],"significantly":[249],"acyclovir\u2019s":[251],"vitro.":[255],"processes":[258],"offer":[259],"strategies":[261],"improvement.":[264]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2026-02-03T00:00:00"}